Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: J Neurosci Res. 2010 Nov 15;88(15):3337–3349. doi: 10.1002/jnr.22483

Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats

Huiyin Tu 1,*, Libin Zhang 1,*, Thai P Tran 1, Robert L Muelleman 1, Yu-Long Li 1,2
PMCID: PMC2953570  NIHMSID: NIHMS225982  PMID: 20857502

Abstract

Voltage-gated sodium (Nav) channels are responsible for initiation and propagation of action potential in the neurons. To explore the mechanisms for chronic heart failure (CHF)-induced baroreflex dysfunction, we measured the expression and current density of Nav channel subunits (Nav1.7, Nav1.8, and Nav1.9) in the aortic baroreceptor neurons and investigated the role of Nav channels on aortic baroreceptor neuron excitability and baroreflex sensitivity in sham and CHF rats. CHF was induced by left coronary artery ligation. The development of CHF (6–8 weeks after the coronary ligation) was confirmed by hemodynamic and morphological characteristics. Immunofluorescent data indicated that Nav1.7 was expressed in A-type (myelinated) and C-type (unmyelinated) nodose neurons but Nav1.8 and Nav1.9 were expressed only in C-type nodose neurons. Real-time RT-PCR and western blot data showed that CHF reduced mRNA and protein expression levels of Nav channels in nodose neurons. In addition, using the whole cell patch-clamp technique, we found that Nav current density and cell excitability of the aortic baroreceptor neurons were lower in CHF rats than that in sham rats. Aortic baroreflex sensitivity was blunted in anesthetized CHF rats, compared with that in sham rats. Furthermore, Nav channel activator (rATX II, 100 nM) significantly enhanced Nav current density and cell excitability of aortic baroreceptor neurons and improved aortic baroreflex sensitivity in CHF rats. These results suggest that reduced expression and activation of the Nav channels is involved in the attenuation of baroreceptor neuron excitability, which subsequently contributes to the impairment of baroreflex in CHF state.

Keywords: Aortic baroreceptor neuron, Baroreflex, Heart failure, Sodium channel


Chronic heart failure (CHF) affects over 5 million Americans with 660,000 new cases diagnosed each year (Rosamond et al., 2008). CHF patients are susceptible to ventricular arrhythmias and ventricular fibrillation, which serve as principal underlying causes of sudden cardiac death (Obias-Manno and Wijetunga, 2004). Loss of baroreceptor reflex sensitivity is thought to mediate the decreased heart rate variability (Binkley et al., 1991), which is a predictive risk factor for ventricular arrhythmia and sudden cardiac death (Kleiger et al., 1987). A blunted baroreflex sensitivity is observed in CHF patients and animals (Creager and Creager, 1994; Floras, 1993; Frenneaux, 2004; Pinna et al., 2005; Ruttanaumpawan et al., 2008; White, 1981).

Arterial baroreflex is a homeostasic mechanism that alters heart rate and blood pressure in response to changes in arterial wall tension detected by mechanosensory nerve terminals in the carotid sinus and aortic arch. The arterial baroreflex includes an afferent limb (baroreceptor neurons), a central neural component, and autonomic neuroeffector components. Central autonomic pathways that mediate the baroreflex are altered and contribute to impaired baroreflex function in CHF(Zucker et al., 1995; Zucker and Liu, 2000). However, a primary defect in the reflex pathway lies with a reduced sensitivity of the baroreceptor afferent fibers (Dibner-Dunlap and Thames, 1989; Rondon et al., 2006; Wang et al., 1990; Wang et al., 1991a; Wang et al., 1991b). Indeed, a recent study indicates that chronic baroreceptor afferent activation enhances the survival rate in dogs with pacing-induced HF (Zucker et al., 2007). Although blunted impulse activity of baroreflex afferents is involved in the blunted baroreflex sensitivity in CHF patients and animals, the mechanism(s) that impair baro-afferent input are still unclear.

Action potentials (electrical impulses) in the aortic baroreceptors (AB) are determined by the voltage-gated sodium (Nav) channels because the Nav channels are responsible for the initiation and propagation of action potentials in the neurons including primary viscerosensory neurons (Ritter et al., 2009; Yu and Catterall, 2003). Until now, nine α subunits (Nav1.1-Nav1.9) of the Nav channels have been functionally characterized and have also been separated by their sensitivity to tetrodotoxin (TTX) into the low activation threshold, fast activating, and inactivating TTX-sensitive (TTX-s) Nav channels (Nav 1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7) and the high activation threshold, slow activating, and inactivating TTX-resistant (TTX-r) Nav channels (Nav1.5, Nav1.8, and Nav1.9) (Catterall et al., 2005; Waxman et al., 1999; Yu and Catterall, 2003). Each Nav channel subunit has a particular tissue localization, consistent with a distinct role for each Nav channel subunit in mammalian physiology (Yu and Catterall, 2003). Nav1.7 (TTX-s), Nav1.8 (TTX-r), and Nav1.9 (TTX-r) are abundantly expressed in the primary sensory neurons such as the nodose ganglion (NG) neurons (Baker and Wood, 2001; Cummins et al., 2007; Kwong et al., 2008; Waxman et al., 1999).

It has been shown that intravenous administration of Nav channel enhancer restores impaired baroreflex sensitivity in conscious dog with CHF (Shen et al., 2005). relatively little else is known about the role of Nav channels in determining the activity of the baroreceptor neurons and arterial baroreflex, especially in the CHF state although some studies have investigated the role of Nav channels in the genesis of the action potential and neuronal discharge in primary sensory neurons (Matsutomi et al., 2006; Patrick and Waxman, 2007; Schild et al., 1994; Schild and Kunze, 1997; Yoshida, 1994). We hypothesize that CHF reduces the expression and activation of Nav channels in the AB neurons. Therefore, our goal in this study was to compare the expression and electrophysiological characteristics of the Nav channels (Nav1.7, Nav1.8, and Nav1.9) in the AB neurons from sham rats with that from CHF rats, and to determine whether the Nav channel dysfunction mediates the blunted arterial baroreflex through attenuating the cell excitability of AB neurons.

MATERIALS AND METHODS

All experimental procedures were approved by the University of Nebraska Medical Center Institutional Animal Care and Use Committee and were carried out in accordance with the National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the American Physiological Society’s Guides for the Care and Use of Laboratory Animals.

CHF animal model

Male Sprague-Dawley rats weighing 180–200 g (6–8 week old) were assigned randomly to one of two groups: CHF (n=44) and sham (n=45). The CHF rats were anesthetized with isoflourane at 2% for surgical ligation of the left coronary artery, just below its exit from the aorta, between the pulmonary artery outflow tract and left atrium. Sham rats underwent the same surgery but the coronary artery was not tied, consistent with the procedure used by other laboratories (Zheng et al., 2006; Zhu et al., 2004). All animals were anesthetized with isoflourane at 2% and cardiac function was measured by echocardiography (VEVO 770, Visual Sonics, Inc) 6–8 wk after coronary ligation or sham operation. In addition, on the day of the terminal experiment, rat was anesthetized with a combination of urethane (800 mg.kg−1, i.p.) and chloralose (80 mg.kg−1, i.p.), and a Millar pressure transducer (SPR 524; size, 3.5-Fr; Millar Instruments, Houston, TX) was advanced through the carotid artery into the left ventricle (LV) to determine LV end-diastolic pressure (LVEDP) and LV systolic pressure. Then in one part of experiments, aortic baroreflex sensitivity was measured (see below). In other part of experiments, both NGs in each rat were acutely removed for immunofluorescent staining, molecular and electrophysiological measurements (see details below). Finally the hearts of all rats were removed and the ratio of infarct area to whole LV minus septum was measured.

Real time RT-PCR measurement of Nav channel mRNA

Total RNA of NGs was extracted using the RNeasy Mini Kit (Qiagen, Valencia, CA). After extraction of mRNA, samples underwent reverse transcription (RT) for 40 min at 37°C in the presence of 1.5 µM of random hexamers and 100 units of MMLV-RTase. Real time RT-PCR measurements were carried out using the PTC-200 Peltier Thermal Cycler with CHROMO 4 Continuous Fluorescence Detector (Bio-Rad). The protocol consisted of denaturation (94°C for 10 min), amplification and quantification repeated 35 cycles (94°C for 15 s, 56°C for 20 s, and 94°C for 20 s). The reaction mixture consisted of SYBR Green Supermix (Bio-Rad), DEPC-treated H2O, the cDNA template of interest, and the primers and probe. The design of primers and probes based on the cDNA sequences of rat Nav channel subunits (Nav1.7, Nav1.8 and Nav1.9) with RPL19 as an internal control (Table 2); and these primers and probes were synthesized in the Eppley DNA Synthesis Core Facility on the campus of the University of Nebraska Medical Center. For quantification, the target genes were normalized by the housekeeping gene RPL19. The data were analyzed by the 2−ΔΔCt method (Livak and Schmittgen, 2001).

Table 2.

Primer sequences for Real-time RT-PCR

Gene Bank
Accession No.
Primer name Primer sequence
NM 133289 Nav1.7 Forward: ATCGCTGTCATCCTGGAGAAC
Reverse: ACCTCGTAGAACATCTCAAAGTCG
   Probe: CGCCACCGAAGAGAGCACTGAGCC
NM 017247 Nav1.8 Forward: CGAGCCCGATGACTGTTTCAC
Reverse: GCCCAAGGAGACTTGCTAGTATTC
   Probe: CACTCGCCGCTGTCCCTGCTGC
NM 019265 Nav1.9 Forward: CGCAGATAGCCGTCGTCTAC
Reverse: GAAGATTTCAAAGTCGTCCTCTCC
   Probe: CCTCGCTCTCCTCCGTGGCTGTGT
NM 031103 RPL19 Forward: CTGAAGGTCAAAGGGAATGTGTTC
Reverse: TTCGTGCTTCCTTGGTCTTAGAC
   Probe: TGCGAGCCTCAGCCTGGTCAGCC

Western blot measurement of Nav channel protein

NGs were rapidly removed, immediately frozen in liquid nitrogen, and stored at −80°C until analyzed. Homogenates were prepared from the NG samples and the proteins were extracted with a lysing buffer (10 mM Tris, 1 mM EDTA, 1% SDS; pH 7.4) plus protease inhibitor cocktail (100 µl ml−1, Sigma). After centrifugation at 12,000 g for 20 min at 4°C, the protein concentration in the supernatant was determined using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL). The protein samples were mixed with the same volume of the loading buffer and heated at 100°C for 5 min. Equal amounts of the protein samples were loaded and then separated on a 7.5% sodium dodecyl sulfate (SDS)-polyacrylamide gel. The proteins of these samples were electrophoretically transferred at 300 mA for 1.5 h onto PVDF membranes. The membranes were blocked with 5% non-fat milk in tris-buffered saline-tween 20, and probed at room temperature with rabbit primary antibodies against Nav channel subunits (Alomone labs), respectively. After washing, the membranes were incubated for 1 h with peroxidase-conjugated goat anti-rabbit secondary antibody (Pierce Chemical, Rockford, IL). The signal was detected using enhanced chemiluminescence substrate (Pierce Chemical, Rockford, IL) and the bands were analyzed using UVP bioimaging system. The blot was reprobed with mouse anti-GADPH antibody (Santa Cruz), allowing normalization of target protein intensity to that of GADPH.

Immunofluorescent staining for Nav channel protein

Immunofluorescent staining was taken in sham (n=7) and CHF (n=7) rats. Each rat was perfused transcardially with 50 ml heparinized saline followed by 150 ml of freshly prepared 4% paraformaldehyde in 0.1 M PBS. Both NGs in each rat were rapidly removed and postfixed in 4% paraformaldehyde in 0.1 M PBS for 12 h at 4°C, followed by soaking the NGs in 30% sucrose for 12 h at 4°C for cryostat protection. Each NG was serially cut into 10 µM-thick cross sections and then mounted on precoated glass slides for immunofluorescent staining.

Experiment 1: In order to determine the population and distribution of A-type and C-type neurons in the NGs from sham and CHF rats, the NG cross sections were incubated with 10% goat serum for 1 h followed by incubation with mouse anti-RT 97 antibody [an A-type neuron marker (Perry et al., 1991), Abcam, Cambridge, MA, USA] overnight at 4°C. Then the sections were washed with PBS and incubated with fluorescence-conjugated secondary antibody (Santa Cruz, CA), Alexa FluorR 488 conjugated isolectin-B4 [IB4, a C-type neuron marker (Wang et al., 1994), Invitrogen, CA], and DAPI (a nucleus marker, Santa Cruz, CA) for 1 h at room temperature. After 3 washes with PBS, slides were observed under a Leica fluorescent microscope with corresponding filters. Pictures were captured by a digital camera system. No staining was seen when PBS was used instead of the primary antibody in the above procedure. Since the slices were 10 µM thick, and the NG neuron soma ranged about 20–50 µM, a same neuron could be double-counted. Therefore, we skipped 7 slices every count to avoid this miscount.

Experiment 2: In order to identify the localization of Nav channels, the colocalization of Nav1.7, Nav1.8, or Nav1.9 channel subunit and RT-97 or IB4 were measured using the same procedure in experiment 1. No staining was seen when PBS was used instead of the primary antibodies or when the mixture of Nav channel antibodies (Alomone labs, Jerusalem, Israel) and appropriate control antigen (Alomone labs, Jerusalem, Israel) was added in the above procedure.

Labeling of AB neurons and isolation of NG neurons

AB neurons in the NGs were selectively retrograde-labeled by a transported fluorescent dye, DiI (red color, Molecular Probes, Eugene. OR) as described previously (Li et al., 2008; Li et al., 1997). Briefly, under sterile condition, rats were anesthetized with isoflourane at 2% for a thoracotomy at the 3rd intercostal space, and DiI (2 µl) was injected into the adventitia of the aortic arch with a fine-tipped glass pipette. After the application of the dye, the surgical incision was closed. After a one-week recovery period to allow the dye to diffuse to the AB neurons in the NGs, the NG neurons were isolated by two-step enzymatic digestion protocol (Li et al., 2008). The isolated cells were resuspended in culture medium and plated onto culture wells. The culture medium consisted of a 50/50 mixture of Delbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium supplemented with antibiotics and 10% fetal bovine serum. The NG cells were cultured at 37°C in a humidified atmosphere of 95% air-5% CO2 for 4–24 h before the patch clamp experiments.

Recording of Nav currents and action potential

Only DiI-labeled NG neurons (AB neurons) were selected for the recording of Nav currents and action potential. Nav currents and action potential were recorded by the whole cell patch-clamp technique using Axopatch 200B patch-clamp amplifier (Axon Instruments, Inc).

In the voltage-clamp experiments, resistance of the patch pipette was 1–3 MΩ when filled with the following solution (in mM): 105 CsCl, 25 TEA, 1 CaCl2, 10 HEPES, 10 EGTA, 5 MgATP, and 25 glucose (pH 7.3; 320 mosm L−1). The extracellular solution consisted of (in mM): 70 NaCl, 10 CsCl, 60 choline-Cl, 0.1 CdCl2, 10 TEA, 4 MgCl2, 10 HEPES, and 10 glucose (pH 7.4; 330 mosm L−1). 70 mM Na+ in extracellular solution was used because normal extracellular Na+ (140 mM) is sufficiently large to saturate the patch clamp amplifier (Ikeda et al., 1986). Series resistance of 5–13 MΩ was electronically compensated 30–80%. Junction potential was calculated to be +9.9 mV using pCLAMP 10.2 software and all values of membrane potential given throughout were corrected using this value. Current traces were sampled at 10 kHz and filtered at 5 kHz. The holding potential was −100 mV and current-voltage (I-V) relationships were elicited by 10 mV step increments to potentials between −90 and 40 mV for 40 ms. Peak currents were measured for each test potential and current density was calculated by dividing peak current by cell membrane capacitance (Cm). In order to separate TTX-s and TTX-r, the cell was exposed to 1 µM TTX in the extracellular bath and the test protocol was repeated. The Nav current inhibited by TTX was defined as TTX-s and the remaining Nav current as TTX-r.

The following procedures were used to isolate Nav1.8 from Nav1.9 in TTX-r currents (Kwong et al., 2008). The patch pipette solution was composed of (in mM): 140 CsF, 10 NaCl, 10 HEPES, 10 EGTA and 2 MgATP (pH 7.3; 320 mosm L−1). The bath solution was composed of (in mM): 70 NaCl, 10 CsCl, 60 choline-Cl, 0.1 CdCl2, 10 TEA, 4 MgCl2, 10 HEPES and 10 glucose (pH 7.4; 330 mosm L−1). Total TTX-r currents were recorded with 80 ms voltage steps from −90 mV to 40 mV from a resting potential of −100 mV in the presence of 1 µM TTX. To isolate the Nav1.8 current, the same voltage protocol was used but with a prepulse of −50 mV for 500 ms prior to the voltage steps for inhibiting Nav1.9 current. Subtraction of the Nav1.8 current from the total TTX-r Nav current yielded the Nav1.9 current.

In the current-clamp experiments, action potential was recorded at current injection of 10–350 pA. The patch pipette solution was composed of (in mM): 145 K-aspartate, 5 NaCl, 1.95 CaCl2, 5 HEPES, 2.2 EGTA, 2 MgCl2, and 10 glucose (pH 7.3; 320 mosm L−1). The bath solution was composed of (in mM): 137 NaCl, 5.4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 glucose (pH 7.4; 330 mosm L−1) (Li et al., 2008). P-clamp 10.2 program (Axon Instruments) was used for data acquisition and analysis. All experiments were done at room temperature.

Recording of aortic baroreflex sensitivity (Fan and Andresen, 1998)

The rat is a useful animal model for the study of baroreflex sensitivity because rat aortic depressor nerve contains only baroreceptor afferent fibers and no chemoreceptor afferent fibers to transmit the chemoreceptor information (Fan et al., 1996; Kobayashi et al., 1999; Sapru et al., 1981; Sapru and Krieger, 1977).

Rat was anesthetized with a combination of urethane (800 mg kg−1, i.p.) and chloralose (80 mg kg−1, i.p.), with supplements of chloralose (10 mg kg−1, i.p.) per 2 h. After a ventral midline incision was made in the neck, the trachea was cannulated, and rat breathed spontaneously. Catheters were implanted into the femoral artery and vein for arterial blood pressure and heart rate measurements and drug administration, respectively. The blood pressure and heart rate were recorded by LabChart 6 (ADInstruments, Colorado Springs, CO).

A 3–5 mm segment of the left aortic depressor nerve was isolated near its junction with the superior laryngeal nerve. The nerve was placed on the stimulating electrodes (bipolar) and covered with mineral oil. All other nerves were intact. Unilateral aortic depressor nerve stimulation was imposed using 10 s of constant-frequency stimulation with 0.1 ms pulse duration and intensity of 18 V, 1–10 Hz (activating C-type) and 10–100 Hz (activating A- and C-type) (Fan and Andresen, 1998). Reflex changes in blood pressure and heart rate related to different stimulating parameters were used as the indices of baroreflex sensitivity for the A- and C-type baroreflex. The effect of Nav channel activator (rATX II) on the baroreflex sensitivity was measured after rATX II (100 nM, 50 nl) was microinjected into NG using a glass micropipette connected to a microinfusion pump (Picospritzer II).

Materials

rATX (Alomone labs) was dissolved in distilled water. We chose the effective concentration of rATX (100 nM, closing to the EC50) in the present study, which was measured in our preliminary experiment for enhancing Nav currents.

Data analysis

All data are presented as means ± SE. SigmaStat 3.5 was used for data analysis. Statistical significance was determined by student’s unpaired t test for hemodynamic and morphological characteristics, and expression of Nav channel subunits. A two-way ANOVA, with a Bonferroni procedure for post hoc was used in comparisons of Nav currents, action potential, and aortic baroreflex sensitivity. All data were confirmed by the Kolmogorov-Smirnov test to fit reasonably within normal distribution and equal variance was confirmed by the Levene test. Statistical significance was accepted when p<0.05. A power analysis was conducted to assess whether the sample size was sufficient to ensure p<0.05.

RESULTS

Hemodynamic and morphological characteristics of sham and CHF rats

Table 1 summarizes the hemodynamic and morphological characteristics of sham and CHF rats. In the CHF rats, a gross examination revealed a dense scar in the arterior ventricular wall and the mean infarct size was 38.1 ± 2.7% of the left ventricular area. In addition, the heart weight and lung weight-to-body weight ratios were significantly higher in CHF rats than that in sham-operated rats, suggesting cardiac hypertrophy and substantial pulmonary congestion in the CHF state. Left ventricular end diastolic pressure was significantly elevated and LV dP/dtmax was decreased in the CHF rats compared with sham rats. Fractional shortening and ejection fraction were attenuated in CHF rats, indicating the development of CHF. However, there were no significant differences in the arterial blood pressure and heart rate between sham and CHF rats.

Table 1.

Hemodynamic and morphological characteristics of sham and CHF rats

Sham (45) CHF (n=44)
Body weight (g) 389 ± 8 401 ± 8
Heart weight (g) 1.41 ± 0.04 2.23 ± 0.05*
Lung weight (g) 2.20 ± 0.06 3.24 ± 0.07*
Heart weight/body weight (mg/g) 3.86 ± 0.08 5.80 ± 0.08*
Lung weight/body weight (mg/g) 5.75 ± 0.09 8.12 ± 0.13*
Infarct size (% of left ventricle) 0 37.9 ± 2.6*
MAP (mm Hg) 92.1 ± 2.9 90.6 ± 3.5
Heart rate (beats/min) 346 ± 7 365 ± 11
LVEDP (mmHg) 1.9 ± 0.6 17.0 ± 1.2*
LVSP (mmHg) 125.5 ± 6.3 98.4 ± 5.7*
LV dP/dtmax (mmHg/s) 8732 ± 382 5318 ± 427*
LVESD (mm) 4.0 ± 0.1 7.8 ± 0.2*
LVEDD (mm) 7.2 ± 0.2 10.3 ± 0.2*
Fractional shortening (%) 44.7 ± 1.1 24.1 ± 1.2*
Ejection fraction (%) 82.6 ± 2.1 41.6 ± 2.9*

Data are means ± SE. CHF, chronic heart failure; MAP, mean arterial pressure; LVEDP, left ventricular end-diastolic pressure; LVSP, left ventricular systolic pressure; LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter.

*

P<0.05 vs. sham.

Population and distribution of A-type and C-type neurons in the NGs from sham and CHF rats

Number of NG neurons and ratio of A-type/C-type neurons in the cross-sectional area of the NGs in sham and CHF rats were measured by the A-type and C-type neuron markers (RT-97 and IB4). We found that there was no co-localization for RT-97 and IB4, and all nuclei of the NG neurons (DAPI, a nucleus marker) nearly merged with the staining of RT-97 plus IB4 (Fig. 1A). These data indicate that it is feasible for using RT-97 and IB4 to separate A-type and C-type neurons in the NGs.

Figure 1.

Figure 1

Ratio of A-type neurons and C-type neurons in NG from sham and CHF rats. The representative (A) and summary (B) data for A- and C-type neuron densities. Caliberation bar: 100 µm. RT-97, A-type neuron marker; IB4, C-type neuron marker; DAPI, cell nucleus marker. Yellow arrows indicate NG neuron nucleus in DAPI staining. Data are mean ± SE, n=16 slices from 4 rats in each group. *P<0.05 vs. sham rats.

The total neuron number and ratio of A-type/C-type neurons were calculated in 16 slices from 4 rats for each group. There is no difference in either total neuron number of nodose neurons (55 ± 6 cells/slice in sham rats and 57 ± 7 cells/slice in CHF rats; p>0.05) or the ratio of A-type/C-type neurons (Fig. 1B) in the NGs between sham and CHF rats.

mRNA and protein expression levels of Nav channel subunits in NGs from sham and CHF rats

Using real time RT-PCR and western blot analyses, we observed that the mRNA and protein expression levels of Nav channel subunits (Nav1.7, Nav1.8, and Nav1.9) were lower in NGs from CHF rats than that from sham rats (Figs. 2 and 3A, p<0.05 vs. sham rats). From immunofluorescent double-staining data, we additionally found that in the sham animals, A-type and C-type NG neurons labeled for the Nav1.7 subunit (Figure 3B), whereas only C-type NG neurons labeled for the Nav1.8 and Nav1.9 subunits (Figure 3C and 3D). In the CHF rats, the protein expression of Nav1.7, Nav1.8, and Nav1.9 subunits in the NG was lowered, compared to the sham rats (Fig. 3B–D).

Figure 2.

Figure 2

Expression of Nav channel subunit mRNA in NG from sham and CHF rats. Data are mean ± SE, n=6 rats in each group. *P<0.05 vs. sham rats.

Figure 3.

Figure 3

A, expression of Nav channel subunit protein in NG from sham and CHF rats, measured by western blot. Data are mean ± SE, n=6 rats in each group. *P<0.05 vs. sham rats. B–D, colocalization of Nav channel subunits (Nav1.7, Nav1.8, and Nav1.9) and RT 97 or IB4 in NG from sham and CHF rats. RT97, A-type neuron marker; IB4, C-type neuron marker.

Nav currents in A- and C-type AB neurons in sham and CHF rats

Nav currents were recorded in the AB neurons selectively labeled by DiI (Fig. 4A). The AB neurons were separated into A-type and C-type neurons by their sensitivity to TTX (Schild and Kunze, 1997).

Figure 4.

Figure 4

A, DiI-labeled AB neurons with red color in fluorescent light (lower) and cells in the same field under regular light (upper). B and C, representative Nav current recording and current density-voltage curves in A-type AB neurons from sham and CHF rats. D, effect of rATX II (100 nM) on Nav current density in A-type AB neurons from CHF rats. Data are mean ± SE, n=9 neuron cells from 9 rats in each group. *P<0.05 vs. sham; #p<0.05 vs. CHF.

In the A-type AB neurons, Nav current was completely blocked by 1 µM TTX in sham and CHF rats, which was named as TTX-s Nav current (Figure 4B). There was no significant difference in whole cell Cm of the A-type AB neurons between sham and CHF rats (49.8 ± 1.3 vs. 51.6 ± 1.5 pF, n=17 cells from 10 sham or 9 CHF rats). Whole-cell Nav current density (pA/pF) in the A-type AB neurons from CHF rats was smaller than that from sham rats (Fig. 4B–D). A Nav channel activator (rATX II, 100 nM) partially increased Nav current density in the A-type AB neurons from CHF rats (Fig. 4D).

In the C-type AB neurons, Nav current was partially decreased by 1 µM TTX in sham and CHF rats, in which the Nav current inhibited by TTX was defined as TTX-s Nav current and the remaining Nav current as TTX-r Nav current (Fig. 5A). Furthermore, TTX-r Nav current was separated into Nav1.8 and Nav1.9 currents by the electrophysiological method (see detail in Methods). There was no significant difference in whole cell Cm of the C-type baroreceptor neurons between sham and CHF rats (37.7 ± 0.8 vs. 38.6 ± 0.9 pF, n=18 cells from 10 sham or 10 CHF rats, p>0.05). All components (Nav1.7, Nav1.8, and Nav1.9) of Nav current density were lowered in the C-type AB neurons from CHF rats, compared with that from sham rats (Fig. 5B–D). rATX II (100 nM) markedly enhanced Nav current density (including Nav1.7, Nav1.8, and Nav1.9) in the C-type AB neurons from CHF rats. However, Nav current density was not recovered to the level seen in sham rats (Fig. 5D).

Figure 5.

Figure 5

A and B, representative Nav current recording and current density-voltage curves in C-type AB neurons from sham and CHF rats. Data are mean ± SE. *P<0.05, CHF total vs. sham total; #p<0.05, CHF TTX-s vs. sham TTX-s; p<0.05, CHF TTX-r vs. sham TTX-r. C, representative Nav1.8 and Nav1.9 current recording in C-type AB neurons. D, effect of rATX II (100 nM) on Nav current density in C-type AB neurons from CHF rats. Data are mean ± SE, n=10 neuron cells from 10 rats in each group. *P<0.05 vs. sham; #p<0.05 vs. CHF.

rATX (100 nM) also increased Nav current density in the A- and C-type AB neurons from sham rats (data not shown).

Cell excitability in A- and C-type AB neurons from sham and CHF rats

Using the ramp current-clamp, we measured current-threshold for inducing action potential. We found that the current-threshold in the A-type AB neurons (31.6 ± 5.8 pA) was different from that in the C-type AB neurons (163.6 ± 13.6 pA) from sham rats. In the CHF rats, the current-threshold in A- and C-type AB neurons was increased (48.7 ± 7.8 and 290 ± 15.6 pA, p<0.05, Fig. 6D), compared with that from sham rats.

Figure 6.

Figure 6

A and B, representative action potential recording in A-type AB neurons from sham and CHF rats. C and D, mean data for number of action potentials and current-threshold for inducing action potential in A- and C-type AB neurons from sham and CHF rats. Data are mean ± SE, n=8 neuron cells from 8 rats in each group. *P<0.05 vs. sham; #p<0.05 vs. CHF.

The number of action potentials was measured in current-clamp (1-sec, 50 pA for A-type neurons and 300 pA for C-type neurons). CHF significantly reduced the number of action potentials in the A- and C-type AB neurons (Fig. 6A–C).

Treatment of rATX (100 nM) markedly decreased the current-threshold, and increased action potential frequency in the A- and C-type AB neurons from CHF rats (Fig. 6C and 5D) and sham rats (data not shown).

Aortic baroreflex sensitivity in sham and CHF rats

Reflex changes in blood pressure and heart rate related to different electrical stimulation of aortic depressor nerve were used as the indices of aortic baroreflex sensitivity. Reflex decreases in blood pressure and heart rate evoked by unilateral steady-frequency aortic depressor nerve stimulation were blunted in anesthetized CHF rats, compared with that in sham rats. Local application of rATX II (100 nM) to the NG enhanced the responses of blood pressure and heart rate to aortic depressor nerve stimulation in CHF and sham rats (Fig. 7). However, local injection of vehicle into the NG did not affect the aortic baroreflex sensitivity in sham and CHF rats.

Figure 7.

Figure 7

Representative tracings (A) and average data (B) showing reflex ΔMAP (mean blood pressure) and ΔHR (heart rate) in response to different frequencies of ADN (aortic depressor nerve) stimulation in anesthetized sham and CHF rats. ABP: arterial blood pressure. Data are mean ± SE, n=6 rats in each group. *P<0.05 vs. sham; #p<0.05 vs. CHF.

DISCUSSION

This is the first study to assess the role of Nav channels in the AB neuron excitability and baroreflex sensitivity in CHF state. The present study showed that: (1) expression of Nav channel mRNA and protein was lower in the NGs from CHF rats than that from sham rats. (2) Nav current density and cell excitability were reduced in A- and C-type AB neurons from CHF rats, compared with that from sham rats; (3) CHF attenuated the aortic baroreflex sensitivity; (4) Nav channel activator (rATX II) significantly enhanced the Nav current density and cell excitability of AB neurons, and improved the baroreflex sensitivity in CHF rats. These results suggest that CHF-induced low expression and hypoactivation of Nav channels mediate the depressed AB neuron excitability and subsequently contribute to the blunted aortic baroreflex sensitivity.

Morphological study has demonstrated that there is no difference in total fiber density, A-type fiber density, C-type fiber density, and ratio of A-/C-type fiber density in carotid sinus nerve between sham and CHF dogs (Wang et al., 1996). Our present study also suggests that there is no change in either total neuron number or the ratio of A-type/C-type neurons in the NGs from CHF rats, compared with those in sham rats. These results provide the important information that the depressed baroreflex in CHF might be not due to the structural changes in the AB neurons but most likely reflect functional changes at the cellular and molecular levels.

In general, the sodium channels in primary afferent neurons can be separated into TTX-s and TTX-r Nav channels. In the dorsal root ganglia, only the TTX-s Nav channels carry the Nav currents in larger diameter low-threshold mechano-sensitive neurons, whereas the TTX-s and TTX-r Nav channels are expressed in smaller diameter nociceptive neurons (Arbuckle and Docherty, 1995; Caffrey et al., 1992; Tate et al., 1998). In the present study, we sought to measure whether the three Nav channel subunits (Nav1.7, Nav1.8, and Nav1.9) mainly expressed in the NG (Kwong et al., 2008) were also differentially distributed in the A-type and C-type NG neurons. The immunofluorescent double-staining is a unique tool to qualify the protein colocalization although it is not reliable enough to perform a quantitative measurement. The results from immunofluorescent and electrophysiological observations indicate that TTX-s Nav channels (Nav1.7) are expressed in A-type and C-type NG neurons but TTX-r Nav channels (Nav1.8 and Nav1.9) are located only in C-type NG neurons. More importantly, CHF significantly decreased the mRNA and protein expression levels of three Nav channel subunits (Figs. 2 and 3) and subsequently blunted the Nav currents in the AB afferent neurons (Figs. 4 and 5).

The mechanisms responsible for mediating afferent sensitivity of barosensitive neurons to pressure are complex and not thoroughly understood. The process of translating changes in arterial wall tension into impulse traffic to the nucleus tractus solitarii (the first site of baroreceptor neuron contacting with central nervous system) involves two broad functional steps: 1) mechanotransduction which is governed by the properties of mechanosensitive ion channels in the nerve terminal and the mechanical properties of the coupling of the arterial wall to the sensory terminal; and 2) spike initiation which is governed by the excitability of membrane voltage sensitive ion channels that influence the electrical (cable) properties of the axonal projection and cell body. All of these factors could be (and likely are) altered in CHF. It is generally assumed that the blunted sensitivity results from an impairment of mechanotransduction at the sensory terminals. In the present study, we observed that the mRNA and protein expression levels and the current density of Nav channels were reduced in the AB neurons from CHF rats. The cell excitability of AB neurons was also suppressed in CHF rats, and a Nav channel activator (rATX II) significantly increased the Nav current density and cell excitability of AB neurons from CHF rats (Figs. 46). Based on these results, we can assume that CHF-lowered expression and activation of Nav channels contributes to the suppressed cell excitability of AB neurons in CHF state (the second process above).

Many studies have used the responses of blood pressure and heart rate to electrical stimulation of baroreceptor-containing nerve for the evaluation of the baroreflex sensitivity in rats (Fan and Andresen, 1998; Salgado et al., 2007; Tang and Dworkin, 2007). Electrical Stimulation of the rat aortic depressor nerve has several advantages to examine the baroreflex function in the present study. First, the rat aortic depressor nerve contains only baroreceptor afferent fibers and no chemoreceptor afferent fibers to transmit the chemoreceptor information (Fan et al., 1996; Kobayashi et al., 1999; Sapru et al., 1981; Sapru and Krieger, 1977); secondly, the baroreflex induced by stimulating rat aortic depressor nerve is measured without the baroreceptor ending in the reflex arc, which allows us to specifically examine the role of electrical excitability of AB in the baroreflex function (second process above); thirdly, by varying the frequency of stimulus, one can differentially activate A- and C- afferent fibers, and thus evaluate the relative contribution of each to the altered Nav channel and baroreflex function in CHF. In the present study, the baroreflex responses of blood pressure and heart rate to the electrical stimulation of the baroreceptor nerve are significantly depressed in CHF rats (Fig. 7). In addition, our present study also found that microinjection of rATX II (Nav channel activator) into the NG significantly improved the baroreflex sensitivity induced by aortic depressor nerve stimulation in CHF rats (Fig. 7). The fact is that nodose neurons are found to influence the conduction and frequency of the electrical impulses in the baroreceptor central axons projecting to the central nervous system when electrical signals in the baroreceptor peripheral axons reach the nodose neurons (Ducreux et al., 1993). One recent review paper (Browning, 2003) has concluded that the excitability of vagal afferent neurons has dramatic consequences for the regulation and modulation of vago-vagal reflex. Furthermore, Devor has reported that electrical excitability of the soma in the dorsal root ganglia may be required to insure the reliable afferent electrical impulses transmitted to the spinal cord (Devor, 1999). These results, taken together, demonstrate that the Nav channel dysfunction of AB neurons contributes to the blunted baroreflex sensitivity through attenuating the AB neuron excitability in CHF rats, which is indirectly confirmed by the finding that rATX also increases the baroreflex sensitivity induced by aortic depressor nerve stimulation in sham rats (Fig. 7B).

We do realize, however, that a disadvantage of the electrical stimulation technique is that it does not represent a physiological substrate for baroreceptor activation. Thus results from reflex experiments evoked by the electrical stimulation needed to be tempered by this limitation. In future, we will further address this issue using baroreflex evoked by changes in arterial blood pressure. However, we also understand that a major limitation to this approach (blood pressure-mediated baroreflex sensitivity) is that possible alterations in the mechanotransduction process at the baro-sensory nerve terminal may also play a role in the suppressed baroreceptor function in response to pressure changes.

Although rATX II significantly increased Nav current density and cell excitability of AB neurons, and improved aortic baroreflex sensitivity in CHF rats, it did not completely normalize these functions towards the level seen in sham rats. Modulating ion channel function usually includes acutely influencing the activation of ion channels and chronically altering the expression of ion channels. Our present study showed the low mRNA and protein expression levels of Nav channels in nodose neurons from CHF rats (Figs. 2 and 3), which could explain the above results because of the inability of rATX to improve the expression of Nav channels. In addition, it is not possible to identify the contribution of the various Nav channel subunits to the cell excitability and baroreflex sensitivity from the present study because no specific Nav channel activators are available for Nav1.7, Nav1.8, and Nav1.9. Further study is needed to explore these outstanding issues.

From the findings that the expression of the three Nav channel subunits is decreased in A-type and C-type nodose neurons from CHF rats (Fig. 3), we cannot clearly confirm the low expression of the Nav channels in the AB neurons from CHF rats due to the limitation of the method (DiI labelling was lost from cells during the immunofluorescent staining procedure and could not be used as a marker of AB neurons with immunofluorescent staining). However, it is reasonable to assume that the protein expression of the Nav channels are lowered in the AB neurons from CHF rats because the AB neurons are a part of the nodose neurons and the whole cell patch-clamp data indicate that the Nav current density is reduced in A-type and C-type AB neurons from CHF rats (Figs. 4 and 5).

In the present study, the Nav currents were recorded in the isolated primary AB neurons cultured in the medium for 4–24 h. It is possible that the culture conditions (such as nerve growth factor in the medium) altered the electrophysiological characteristics of the Nav channels in the AB neuron cells. However, this is not likely because our preliminary data have found that the Nav currents recorded in the acutely dissociated neurons are same as that obtained in the AB neurons cultured in the medium at 24 h regardless of sham or CHF rats, which is consistent with data from Kwong’s study (Kwong et al., 2008).

The mechanism(s) responsible the down-regulation of the Nav channel expression and function in the AB neurons from CHF rats are not understood. One possible candidate is angiotensin II (Ang II)-superoxide-nuclear factor kappa B (NFκB) signaling pathway. CHF elevated endogenous Ang II levels in animal models and in humans (Li et al., 2006; Roig et al., 2000; Schunkert et al., 1993). Ang II can induce superoxide production in many cell types through NADPH oxidase activation and mitochondrial dysfunction (Touyz and Berry, 2002; Zhang et al., 2007). Recent study has shown that reactive oxygen species down-regulates cardiac Nav1.5 channel expression via NFκB activation (Shang et al., 2008). Further study is needed to explore how the Nav channel expression and activation are reduced in the AB neurons from CHF rats.

In conclusion, our results suggest that reduced expression and activation of Nav channels mediates the suppressed cell excitability of AB neurons and subsequently contributes to the blunted baroreflex sensitivity in CHF state. The results of this study provide important information that improving the Nav channel function in the baroreceptor neurons is a new therapeutic strategy for the baroreflex impairment in CHF.

Acknowledgments

Grant information: This work was supported by National Heart, Lung, and Blood Institute Grant HL-098503 to Y.L. Li

Footnotes

DISCLOSURES

No conflicts of interest are declared by the author(s).

REFERENCES

  1. Arbuckle JB, Docherty RJ. Expression of tetrodotoxin-resistant sodium channels in capsaicin-sensitive dorsal root ganglion neurons of adult rats. Neurosci. Lett. 1995;185:70–73. doi: 10.1016/0304-3940(94)11227-a. [DOI] [PubMed] [Google Scholar]
  2. Baker MD, Wood JN. Involvement of Na+ channels in pain pathways. Trends Pharmacol. Sci. 2001;22:27–31. doi: 10.1016/s0165-6147(00)01585-6. [DOI] [PubMed] [Google Scholar]
  3. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J. Am. Coll. Cardiol. 1991;18:464–472. doi: 10.1016/0735-1097(91)90602-6. [DOI] [PubMed] [Google Scholar]
  4. Browning KN. Excitability of nodose ganglion cells and their role in vago-vagal reflex control of gastrointestinal function. Curr. Opin. Pharmacol. 2003;3:613–617. doi: 10.1016/j.coph.2003.06.011. [DOI] [PubMed] [Google Scholar]
  5. Caffrey JM, Eng DL, Black JA, Waxman SG, Kocsis JD. Three types of sodium channels in adult rat dorsal root ganglion neurons. Brain Res. 1992;592:283–297. doi: 10.1016/0006-8993(92)91687-a. [DOI] [PubMed] [Google Scholar]
  6. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 2005;57:397–409. doi: 10.1124/pr.57.4.4. [DOI] [PubMed] [Google Scholar]
  7. Creager MA, Creager SJ. Arterial baroreflex regulation of blood pressure in patients with congestive heart failure. J. Am. Coll. Cardiol. 1994;23:401–405. doi: 10.1016/0735-1097(94)90427-8. [DOI] [PubMed] [Google Scholar]
  8. Cummins TR, Sheets PL, Waxman SG. The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain. 2007;131:243–257. doi: 10.1016/j.pain.2007.07.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Devor M. Unexplained peculiarities of the dorsal root ganglion. Pain Suppl. 1999;6:S27–S35. doi: 10.1016/S0304-3959(99)00135-9. [DOI] [PubMed] [Google Scholar]
  10. Dibner-Dunlap ME, Thames MD. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreceptor sensitivity. Circ. Res. 1989;65:1526–1535. doi: 10.1161/01.res.65.6.1526. [DOI] [PubMed] [Google Scholar]
  11. Ducreux C, Reynaud JC, Puizillout JJ. Spike conduction properties of T-shaped C neurons in the rabbit nodose ganglion. Pflugers Arch. 1993;424:238–244. doi: 10.1007/BF00384348. [DOI] [PubMed] [Google Scholar]
  12. Fan W, Andresen MC. Differential frequency-dependent reflex integration of myelinated and nonmyelinated rat aortic baroreceptors. Am. J Physiol. 1998;275:H632–H640. doi: 10.1152/ajpheart.1998.275.2.H632. [DOI] [PubMed] [Google Scholar]
  13. Fan W, Reynolds PJ, Andresen MC. Baroreflex frequency-response characteristics to aortic depressor and carotid sinus nerve stimulation in rats. Am. J Physiol. 1996;271:H2218–H2227. doi: 10.1152/ajpheart.1996.271.6.H2218. [DOI] [PubMed] [Google Scholar]
  14. Floras JS. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 1993;22:72A–84A. doi: 10.1016/0735-1097(93)90466-e. [DOI] [PubMed] [Google Scholar]
  15. Frenneaux MP. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart. 2004;90:1248–1255. doi: 10.1136/hrt.2003.026146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ikeda SR, Schofield GG, Weight FF. Na+ and Ca2+ currents of acutely isolated adult rat nodose ganglion cells. J Neurophysiol. 1986;55:527–539. doi: 10.1152/jn.1986.55.3.527. [DOI] [PubMed] [Google Scholar]
  17. Kleiger RE, Miller JP, Bigger JT, Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am. J. Cardiol. 1987;59:256–262. doi: 10.1016/0002-9149(87)90795-8. [DOI] [PubMed] [Google Scholar]
  18. Kobayashi M, Cheng ZB, Tanaka K, Nosaka S. Is the aortic depressor nerve involved in arterial chemoreflexes in rats? J Auton. Nerv. Syst. 1999;78:38–48. doi: 10.1016/s0165-1838(99)00054-5. [DOI] [PubMed] [Google Scholar]
  19. Kwong K, Carr MJ, Gibbard A, Savage TJ, Singh K, Jing J, Meeker S, Undem BJ. Voltage-gated sodium channels in nociceptive versus non-nociceptive nodose vagal sensory neurons innervating guinea pig lungs. J. Physiol. 2008;586:1321–1336. doi: 10.1113/jphysiol.2007.146365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Li YL, Tran TP, Muelleman R, Schultz HD. Blunted excitability of aortic baroreceptor neurons in diabetic rats: involvement of hyperpolarization-activated channel. Cardiovasc. Res. 2008;79:715–721. doi: 10.1093/cvr/cvn141. [DOI] [PubMed] [Google Scholar]
  21. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, Patel KP, Wang W, Schultz HD. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 2006;71:129–138. doi: 10.1016/j.cardiores.2006.03.017. [DOI] [PubMed] [Google Scholar]
  22. Li Z, Lee HC, Bielefeldt K, Chapleau MW, Abboud FM. The prostacyclin analogue carbacyclin inhibits Ca(2+)-activated K+ current in aortic baroreceptor neurones of rats. J Physiol. 1997;501(Pt 2):275–287. doi: 10.1111/j.1469-7793.1997.275bn.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
  24. Matsutomi T, Nakamoto C, Zheng T, Kakimura J, Ogata N. Multiple types of Na(+) currents mediate action potential electrogenesis in small neurons of mouse dorsal root ganglia. Pflugers Arch. 2006;453:83–96. doi: 10.1007/s00424-006-0104-3. [DOI] [PubMed] [Google Scholar]
  25. Obias-Manno D, Wijetunga M. Risk stratification and primary prevention of sudden cardiac death: sudden death prevention. AACN. Clin. Issues. 2004;15:404–418. doi: 10.1097/00044067-200407000-00008. [DOI] [PubMed] [Google Scholar]
  26. Patrick HT, Waxman SG. Inactivation properties of sodium channel Nav1.8 maintain action potential amplitude in small DRG neurons in the context of depolarization. Mol. Pain. 2007;3:12. doi: 10.1186/1744-8069-3-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Perry MJ, Lawson SN, Robertson J. Neurofilament immunoreactivity in populations of rat primary afferent neurons: a quantitative study of phosphorylated and non-phosphorylated subunits. J Neurocytol. 1991;20:746–758. doi: 10.1007/BF01187848. [DOI] [PubMed] [Google Scholar]
  28. Pinna GD, Maestri R, Capomolla S, Febo O, Robbi E, Cobelli F, La Rovere MT. Applicability and clinical relevance of the transfer function method in the assessment of baroreflex sensitivity in heart failure patients. J. Am. Coll. Cardiol. 2005;46:1314–1321. doi: 10.1016/j.jacc.2005.06.062. [DOI] [PubMed] [Google Scholar]
  29. Ritter AM, Martin WJ, Thorneloe KS. The voltage-gated sodium channel Nav1.9 is required for inflammation-based urinary bladder dysfunction. Neurosci. Lett. 2009;452:28–32. doi: 10.1016/j.neulet.2008.12.051. [DOI] [PubMed] [Google Scholar]
  30. Roig E, Perez-Villa F, Morales M, Jimenez W, Orus J, Heras M, Sanz G. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur. Heart J. 2000;21:53–57. doi: 10.1053/euhj.1999.1740. [DOI] [PubMed] [Google Scholar]
  31. Rondon E, Brasileiro-Santos MS, Moreira ED, Rondon MU, Mattos KC, Coelho MA, Silva GJ, Brum PC, Fiorino P, Irigoyen MC, Krieger EM, Middlekauff HR, Negrao CE. Exercise training improves aortic depressor nerve sensitivity in rats with ischemia-induced heart failure. Am. J. Physiol Heart Circ. Physiol. 2006;291:H2801–H2806. doi: 10.1152/ajpheart.01352.2005. [DOI] [PubMed] [Google Scholar]
  32. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25–e146. doi: 10.1161/CIRCULATIONAHA.107.187998. [DOI] [PubMed] [Google Scholar]
  33. Ruttanaumpawan P, Gilman MP, Usui K, Floras JS, Bradley TD. Sustained effect of continuous positive airway pressure on baroreflex sensitivity in congestive heart failure patients with obstructive sleep apnea. J. Hypertens. 2008;26:1163–1168. doi: 10.1097/HJH.0b013e3282fb81ed. [DOI] [PubMed] [Google Scholar]
  34. Salgado HC, Barale AR, Castania JA, Machado BH, Chapleau MW, Fazan R., Jr Baroreflex responses to electrical stimulation of aortic depressor nerve in conscious SHR. Am. J Physiol Heart Circ. Physiol. 2007;292:H593–H600. doi: 10.1152/ajpheart.00181.2006. [DOI] [PubMed] [Google Scholar]
  35. Sapru HN, Gonzalez E, Krieger AJ. Aortic nerve stimulation in the rat: cardiovascular and respiratory responses. Brain Res. Bull. 1981;6:393–398. doi: 10.1016/s0361-9230(81)80009-3. [DOI] [PubMed] [Google Scholar]
  36. Sapru HN, Krieger AJ. Carotid and aortic chemoreceptor function in the rat 185. J Appl. Physiol. 1977;42:344–348. doi: 10.1152/jappl.1977.42.3.344. [DOI] [PubMed] [Google Scholar]
  37. Schild JH, Clark JW, Hay M, Mendelowitz D, Andresen MC, Kunze DL. A- and C-type rat nodose sensory neurons: model interpretations of dynamic discharge characteristics. J. Neurophysiol. 1994;71:2338–2358. doi: 10.1152/jn.1994.71.6.2338. [DOI] [PubMed] [Google Scholar]
  38. Schild JH, Kunze DL. Experimental and modeling study of Na+ current heterogeneity in rat nodose neurons and its impact on neuronal discharge. J. Neurophysiol. 1997;78:3198–3209. doi: 10.1152/jn.1997.78.6.3198. [DOI] [PubMed] [Google Scholar]
  39. Schunkert H, Tang SS, Litwin SE, Diamant D, Riegger G, Dzau VJ, Ingelfinger JR. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc. Res. 1993;27:731–735. doi: 10.1093/cvr/27.5.731. [DOI] [PubMed] [Google Scholar]
  40. Shang LL, Sanyal S, Pfahnl AE, Jiao Z, Allen J, Liu H, Dudley SC., Jr NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am. J. Physiol Cell Physiol. 2008;294:C372–C379. doi: 10.1152/ajpcell.00186.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shen W, Gill RM, Zhang JP, Jones BD, Corbly AK, Steinberg MI. Sodium channel enhancer restores baroreflex sensitivity in conscious dogs with heart failure. Am. J Physiol Heart Circ. Physiol. 2005;288:H1508–H1514. doi: 10.1152/ajpheart.00337.2004. [DOI] [PubMed] [Google Scholar]
  42. Tang X, Dworkin BR. Baroreflexes of the rat. V. Tetanus-induced potentiation of ADN A-fiber responses at the NTS. Am. J Physiol Regul. Integr. Comp Physiol. 2007;293:R2254–R2259. doi: 10.1152/ajpregu.00143.2007. [DOI] [PubMed] [Google Scholar]
  43. Tate S, Benn S, Hick C, Trezise D, John V, Mannion RJ, Costigan M, Plumpton C, Grose D, Gladwell Z, Kendall G, Dale K, Bountra C, Woolf CJ. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons. Nat. Neurosci. 1998;1:653–655. doi: 10.1038/3652. [DOI] [PubMed] [Google Scholar]
  44. Touyz RM, Berry C. Recent advances in angiotensin II signaling. Braz. J Med. Biol. Res. 2002;35:1001–1015. doi: 10.1590/s0100-879x2002000900001. [DOI] [PubMed] [Google Scholar]
  45. Wang H, Rivero-Melian C, Robertson B, Grant G. Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience. 1994;62:539–551. doi: 10.1016/0306-4522(94)90387-5. [DOI] [PubMed] [Google Scholar]
  46. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation. 1990;81:1959–1966. doi: 10.1161/01.cir.81.6.1959. [DOI] [PubMed] [Google Scholar]
  47. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ. Res. 1991a;68:1294–1301. doi: 10.1161/01.res.68.5.1294. [DOI] [PubMed] [Google Scholar]
  48. Wang W, Chen JS, Zucker IH. Postexcitatory depression of baroreceptors in dogs with experimental heart failure. Am. J Physiol. 1991b;260:H1160–H1165. doi: 10.1152/ajpheart.1991.260.4.H1160. [DOI] [PubMed] [Google Scholar]
  49. Wang W, Han HY, Zucker IH. Depressed baroreflex in heart failure is not due to structural change in carotid sinus nerve fibers. J Auton. Nerv. Syst. 1996;57:101–108. doi: 10.1016/0165-1838(95)00107-7. [DOI] [PubMed] [Google Scholar]
  50. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc. Natl. Acad. Sci. U. S. A. 1999;96:7635–7639. doi: 10.1073/pnas.96.14.7635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. White CW. Abnormalities in baroreflex control of heart rate in canine heart failure. Am. J. Physiol. 1981;240:H793–H799. doi: 10.1152/ajpheart.1981.240.5.H793. [DOI] [PubMed] [Google Scholar]
  52. Yoshida S. Tetrodotoxin-resistant sodium channels. Cell Mol. Neurobiol. 1994;14:227–244. doi: 10.1007/BF02088322. [DOI] [PubMed] [Google Scholar]
  53. Yu FH, Catterall WA. Overview of the voltage-gated sodium channel family. Genome Biol. 2003;4:207. doi: 10.1186/gb-2003-4-3-207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zhang GX, Lu XM, Kimura S, Nishiyama A. Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation. Cardiovasc. Res. 2007;76:204–212. doi: 10.1016/j.cardiores.2007.07.014. [DOI] [PubMed] [Google Scholar]
  55. Zheng H, Li YF, Zucker IH, Patel KP. Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure. Am. J Physiol Renal Physiol. 2006;291:F1148–F1156. doi: 10.1152/ajprenal.00501.2005. [DOI] [PubMed] [Google Scholar]
  56. Zhu GQ, Gao L, Li Y, Patel KP, Zucker IH, Wang W. AT1 receptor mRNA antisense normalizes enhanced cardiac sympathetic afferent reflex in rats with chronic heart failure. Am. J Physiol Heart Circ. Physiol. 2004;287:H1828–H1835. doi: 10.1152/ajpheart.01245.2003. [DOI] [PubMed] [Google Scholar]
  57. Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007;50:904–910. doi: 10.1161/HYPERTENSIONAHA.107.095216. [DOI] [PubMed] [Google Scholar]
  58. Zucker IH, Liu JL. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail. Rev. 2000;5:27–43. doi: 10.1023/A:1009894007055. [DOI] [PubMed] [Google Scholar]
  59. Zucker IH, Wang W, Brandle M, Schultz HD, Patel KP. Neural regulation of sympathetic nerve activity in heart failure. Prog. Cardiovasc. Dis. 1995;37:397–414. doi: 10.1016/s0033-0620(05)80020-9. [DOI] [PubMed] [Google Scholar]

RESOURCES